MAPT and meningoencephalitis: The present observations have provided evidence for the therapeutic potency of a viral vector-assisted active immunization directed against these non-fibrillar tau proteins, as well as for its safe properties without marked emergences of deleterious microgliosis and T-lymphocyte43 meningoencephalitis.